Combating the great mimicker: latest progress in the development of Burkholderia pseudomallei vaccines.

Expert Review of Vaccines
Nittaya KhakhumAlfredo G Torres

Abstract

Introduction Burkholderia pseudomallei is an environmental intracellular Gram-negative bacterium that causes melioidosis, a severe infectious disease affecting humans and animals. An increase in melioidosis cases worldwide and the high mortality rate of the disease makes it a public health concern. Melioidosis is known as the 'great mimicker' because it presents with a wide range of disease manifestations. B. pseudomallei is naturally resistant to antibiotics and delay in diagnosis leads to ineffective treatment. Furthermore, there is no approved vaccine to prevent melioidosis infection in humans. Therefore, it is a priority to license a vaccine that can be used for both high-risk endemic areas and for biodefense purposes. Areas covered In this review, we have focussed on recent progress in the USA for the development and advancement of lead B. pseudomallei vaccine candidate(s) ready for testing in pre-clinical trials. Those candidates include live-attenuated vaccines, glycoconjugate vaccines, outer-membrane vesicles, and gold nanoparticle vaccines. Expert opinion Side-by-side comparison of the leading B. pseudomallei vaccine candidates will provide important information to further advance studies into pre-clinical trials. The ...Continue Reading

References

Mar 1, 1996·Infection and Immunity·A L JonesD E Woods
Mar 19, 2002·Emerging Infectious Diseases·Lisa D RotzJames M Hughes
Aug 7, 2003·Expert Review of Vaccines·Jonathan Warawa, Donald E Woods
Apr 16, 2005·Clinical Microbiology Reviews·Allen C Cheng, Bart J Currie
Jan 2, 2008·Transactions of the Royal Society of Tropical Medicine and Hygiene·Bart J Currie
Jan 16, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·Bart J CurrieAllen C Cheng
Apr 28, 2010·Annual Review of Microbiology·Nicholas NoinajSusan K Buchanan
Jun 4, 2010·The American Journal of Tropical Medicine and Hygiene·Direk LimmathurotsakulSharon J Peacock
Sep 10, 2010·Annual Review of Microbiology·Adam Kulp, Meta J Kuehn
Dec 15, 2010·PLoS Neglected Tropical Diseases·Bart J CurrieAllen C Cheng
Sep 14, 2012·The New England Journal of Medicine·W Joost WiersingaSharon J Peacock
Aug 21, 2013·Human Vaccines & Immunotherapeutics·Michael E Pichichero
Mar 29, 2014·Clinical and Vaccine Immunology : CVI·Wildaliz NievesLisa A Morici
Aug 29, 2014·Procedia in Vaccinology·Hailey PetersenLisa A Morici
Sep 10, 2014·Nanomedicine : Nanotechnology, Biology, and Medicine·Anthony E GregoryRichard W Titball
Feb 3, 2015·Seminars in Respiratory and Critical Care Medicine·Bart J Currie
May 21, 2015·Emerging Infectious Diseases·Direk LimmathurotsakulUNKNOWN Steering Group on Melioidosis Vaccine Development
Oct 27, 2015·PLoS Neglected Tropical Diseases·Kemajittra JenjaroenSusanna J Dunachie
Feb 16, 2016·Nature Microbiology·Direk LimmathurotsakulSimon I Hay
Apr 16, 2016·Future Microbiology·Laura A Muruato, Alfredo G Torres
Aug 31, 2016·Nature Microbiology·Direk LimmathurotsakulSimon I Hay
Sep 14, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Katherine A Rhodes, Herbert P Schweizer
Sep 15, 2017·Clinical and Vaccine Immunology : CVI·Laura A MuruatoAlfredo G Torres
Mar 1, 2005·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·A C ChengB J Currie
Feb 2, 2018·Nature Reviews. Disease Primers·W Joost WiersingaDirek Limmathurotsakul
Jul 6, 2019·BMC Medicine·Nantasit LuangasanatipMark Jit

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

© 2021 Meta ULC. All rights reserved